 |
Speakers and titles of APSTH/JSTH joint symposium in 2022 |
04/14,2022 |
|
Speakers and titles of APSTH/JSTH joint symposium in 2022 are as follows. Sun Young Choi (Korea) Evaluation of Bleeding Events in Patients with Atrial Fibrillation Receiving Concomitant Oral Anticoagulant-Antiplatelets; Sang-A Kim (Korea) Treatment and bleeding complications of cancer-associated venous thromboembolism: A Korean population-based study; Yuefen Hu (China) The effects of Eltrombopag on the IFN-α-induced anti-viral immune response in the treatment of HBV-ITP; Anli Liu (China) HDAC3 single-nucleotide polymorphism rs2530223 is associated with increased susceptibility and severity of primary immune thrombocytopenia; Jing Qin (China) Empagliflozin modulates CD4 T cell differentiation via metabolic reprogramming in immune thrombocytopenia; Liu Qiang (China) Short-chain fatty acids restore the monocyte/macrophage system in ITP via epigenetic-metabolic reprogramming; Xuan Jin (Korea) Platelet Reactivity and Prognostic Implication After Drug-Eluting Stent Implantation in Patients with Complex PCI: Results From the PTRG-DES Registry; Zhao Yan Song (Korea) Differences in Optimal Platelet Reactivity after New P2Y12 Inhibitor Treatment in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.
|

|
|
 |